Related Experiment Video
Updated: Aug 12, 2026
04:38
Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
Published on: April 19, 2024
[Complication rate after thoracoscopic and conventional lobectomy]
Beatrix Hoksch1, B Ablassmaier, M Walter
1Klinik und Poliklinik für Chirurgie, Charité Campus Mitte, Medizinische Fakultät der Humboldt-Universität zu Berlin. hoksch@t-online.de
Zentralblatt Fur Chirurgie
|March 13, 2003
Summary
Thoracoscopic lobectomy for non-small cell lung cancer results in significantly lower postoperative morbidity compared to conventional thoracotomy. This minimally invasive approach offers a safer alternative for patients.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
Background:
- Primary non-small cell lung cancer (NSCLC) treatment often involves surgical resection.
- Conventional thoracotomy carries a significant postoperative morbidity risk.
- Minimally invasive techniques are increasingly explored to improve surgical outcomes.
Purpose of the Study:
- To compare the postoperative morbidity rates of thoracoscopic lobectomy versus conventional thoracotomy for primary NSCLC.
- To evaluate the safety and efficacy of minimally invasive lobectomy in NSCLC treatment.
Main Methods:
- A prospective analysis of 42 patients diagnosed with lung cancer.
- Patients underwent either thoracoscopic lobectomy (n=28) or conventional lobectomy (n=14).
- Postoperative complication rates within 30 days were assessed; groups were comparable in age, comorbidity, tumor location, and stage.
Main Results:
- The conventional thoracotomy group exhibited a significantly higher morbidity rate (50%) compared to the thoracoscopic lobectomy group (14.2%, p=0.03).
- Thoracoscopic lobectomy demonstrated a substantially lower complication rate.
Conclusions:
- Thoracoscopic lobectomy is a safe and effective surgical option for primary NSCLC.
- This minimally invasive approach offers a viable and less morbid alternative to conventional thoracotomy.
